Akèy › Kansè Vezik ki pa envazif miskilè › Washington
Etid klinik pou Kansè Vezik ki pa envazif miskilè nan Washington
5 etid pou Kansè Vezik ki pa envazif miskilè ap chèche patisipan nan sit nan Washington.
Vil nan Washington
Tèks ofisyèl etid la (Anglè)
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
- University of Washington - Fred Hutchinson Cancer Center ( Site 0100), Seattle
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06833073A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
- University of Washington School of Medicine, Seattle
- Spokane Urology, Spokane
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07309445Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
- Spokane Urology, Spokane
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT05951179Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jul 31, 2026 · NCT07225127Blue Light Cystoscopy With Cysview® Registry
- University of Washington Medicine, Seattle
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Dec 18, 2025 · NCT02660645Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.